Federal contractor · GUNPO-SI

CHENKWANG SCIENCE

CHENKWANG SCIENCE received $34K in federal contract obligations in FY2026, on 1 awards (+11% vs FY2025). Since FY2019: $327K. Its largest customer was Defense Health Agency ($34K).

Obligations · FY2026
$34K
New awards
1
Sole-source
100%
Single offer
0.0%
UEI
M7HGNKTZLU73
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 22.7KFY2019
  2. 52.9KFY2020
  3. 84.2KFY2021
  4. 42.6KFY2022
  5. 37KFY2023
  6. 23.1KFY2024
  7. 30.6KFY2025
  8. 34KFY2026

Top buying agencies

Obligations in FY2026.

  1. Defense Health Agency$34K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$34K100%

Where the work was performed

  1. Abroad$34K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $34K
  • Sole-source awards100%
    US 30% · $34K
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. BIOMERIEUX REAGENTS FOR BDAACH$34K
    Defense Health Agency· Health & medical· Aug 26, 2025 – May 22, 2026· W81K0225FA112

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

  1. THE REPUBLIC OF KOREA NATIONAL RED CROSS$96K−27% in FY2026
    SUWON, KOR · 82% of this company's obligations are in markets they both serveArmy · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturing
  2. NAMU MED$144K+31% in FY2026
    SEOUL, KOR · 100% of this company's obligations are in markets they both serveArmy · Pharmaceutical and medicine manufacturingDefense Health Agency · Pharmaceutical and medicine manufacturing
  3. INSEONMEDICS INC.$68.2K−4% in FY2026
    SEOUL, KOR · 65% of this company's obligations are in markets they both serveDefense Health Agency · Pharmaceutical and medicine manufacturingArmy · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.